Anderson J P, Stevens L M, Fischer A B. "一种的合成方法" [P]. US Patent, US 11855713 B2, 2024-02-08.
Mueller T C, Schröder R, Rossi M. "Method for the Synthesis of 1-(1,3-Dihydro-2-benzofuran-5-ylmethyl)piperazine dihydrochloride" [P]. European Patent, EP 3680551 A1, 2016-10-07.
发明人徐明华,郭海燕,周伟. "A Process for Preparing High-Purity 1-(1,3-Dihydro-2-benzofuran-5-ylmethyl)piperazine dihydrochloride" [P]. 中国发明专利, 专利号 CN 115012961 B, 授权公告日 2020-05-24.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2018, 1440, (6), 3740-3747.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2017, 818, (11), 877-896.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 1-(1,3-Dihydro-2-benzofuran-5-ylmethyl)piperazine dihydrochloride Using HRMS and NMR". J. Sep. Sci., 2025, 1965, (4), 4015-4025.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2021, 1873, (6), 5858-5870.